What is NVO's current stock price?

As of now, NVO is trading at $57.12, with a daily change of -3.05%.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

NVO Stock Analysis & IQ Rating | Novo Nordisk A/S

NVO NVO Badge

Novo Nordisk A/S

$57.12

-$1.79 | -3.05%

Set Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$93.8

MKT CAP

$193.74B

52W Low

$43.08

VOL

$25.62M

P/E Ratio

15.71

AVG VOL

$17.66M

RSI

62.21

TREND

Uptrend

NVO Stock IQ

Login to see Novo Nordisk A/S (NVO) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

NVO Target Price

Login to display

Strengths

NVO Rewards

Earnings are forecast to grow

NVO Rewards

Trading below its fair value

NVO Rewards

Upgraded on attractively valued

NVO Rewards

Investors confidence is positive

NVO Price Performance

$47.77 (+19.57%)

$55.74 (+2.48%)

$56.98 (+0.25%)

$84.45 (-32.36%)

1year

6month

3month

1month

NVO Risk Level

NVO has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.

Click here to check what is your level of risk

Risks Indicators

Investors losing confidence

Hit 52-week low

Low

LOW

HIGH

NVO Analysts Opinion

NVO overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

NVO Analysts Opinion

NVO Analysts opinion is negative and it remained unchanged from the past 3 months

NVO Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

74%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

36%

86%

NVO Street Sentiment

NVO Street Sentiment is bullish and have positive views on the near-term outlook

NVO Performance Sentiment

Sentiments overview associated with NVO events and the stock performance.

74%

16%

Positive

Negative

32 out of 43
events present

7 out of 43
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Support
Price

$58.91

Resistance
Price

$45.68

Current Price Range

$60.00

Show methods +

Linked to NVO

IQ

Close Price

Change

LLY

4.21

1032.97

-3.76%

PFE

4.25

25.89

+1.21%

LEXX

1.55

0.73

-6.53%

VKTX

3.90

31.86

-7.21%

SNY

3.94

47.47

-0.88%

Recently Viewed

Close Price

Change

JANX

Janux Therapeutics I

13.72

-2.83%

NVO

Novo Nordisk A/S

57.12

-3.05%

CXDO

Crexendo

7.38

+2.93%

JCSE

JE Cleantech Holdings

1.59

-17.62%

TALO

Talos Energy

11.63

-2.84%

NVO Latest Analysis +

Novo Nordisk Stock Dips As Company Faces GLP-1 Antitrust Lawsuit. ) .Novo Nordisk stock is feeling bearish pressure. Strive Specialties filed a lawsuit on Wednesday in a federal district court in San Antonio Texas alleging that Novo Nordisk and

Today

$57.12 | -3.05%

Momentum

Novo Nordisk stock target raised at UBS ahead of Wegovy Pill launch.

Today

$57.12 | -3.05%

Activity

Potential

Novo Nordisk Foundation grants DKK 5.5 billion to elevate innovation in Denmark and Europe. COPENHAGEN Denmark Jan. 15 2026 /PRNewswire/ -- The Novo Nordisk Foundation has allocated up to DKK 5.5 billion (EUR 736 million) to BioInnovation Institute (BII) a leading institute for life science and deep tech innovation in Copenhagen. The funding will enable BII to expand its...

Today

$57.12 | -3.05%

Activity

Novo Nordisk A/S (NOVO:CA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript.

Tue Jan 13, 2026

$59.61 | -0.34%

Activity

Novo Nordisk Soars 19% in a Month: How Should You Play the Stock?. NVO jumps nearly 19% in a month primarily on the FDA approval and launch of oral Wegovy the first GLP-1 pill for obesity and cardiovascular risk reduction.

Tue Jan 13, 2026

$59.61 | -0.34%

Activity

Momentum

Novo Nordisk flags near-term headwinds in international markets.

Tue Jan 13, 2026

$59.61 | -0.34%

Potential

Can Novo Nordisk Unseat Eli Lilly as the Weight Loss Drug Leader in 2026?. Key PointsNovo Nordisk launched an oral version of its best-selling weight management medicine.

Tue Jan 13, 2026

$59.61 | -0.34%

Activity

Looking At Novo Nordisks Recent Unusual Options Activity. Deep-pocketed investors have adopted a bearish approach towards Novo Nordisk (NYSE:) and it'.s something market players shouldn'.t ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown but such a substantial move in NVO usually suggests something big is about to happen.We gleaned this information from our observations today when Benzinga

Mon Jan 12, 2026

$59.86 | +1.79%

Momentum

Novo Nordisk (NVO) Surpasses Market Returns: Some Facts Worth Knowing. Novo Nordisk (NVO) concluded the recent trading session at $57.34 signifying a 1.36% move from its prior days close.

Thu Jan 8, 2026

$57.34 | +1.37%

Momentum

Novo Nordisk: My Top Pick For 2026.

Thu Jan 8, 2026

$57.34 | +1.37%

Potential

FAQ About NVO Stock Insights

What is NVO current stock price?

What are NVO stock strengths?

What is NVO Risk Level?

What is NVO market cap and volume?

What is NVO current Stock IQ?

Should I buy NVO stock right now?

Is NVO a Strong Buy right now?

What does a 'Strong Buy' rating mean for NVO?

What does a 'Strong Sell' rating mean for NVO?

What factors influence NVO's Stock IQ?

Explore our NVO Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored NVO Stock Strategies
Effective Risk Management

FIND US ON

Receive our NVO Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

NVO NVO Badge

Novo Nordisk A/S

Set Alerts

Current Price

$57.12

-$1.79 | -3.05%

52W High

$93.8

MKT CAP

$193.74B

52W Low

$43.08

VOL

$25.62M

P/E Ratio

15.71

AVG VOL

$17.66M

RSI

62.21

TREND

Uptrend

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

NVO Stock IQ

Login to unlock Novo Nordisk A/S (NVO) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Target Price

Login to display

Stock Insights

Strengths

NVO Rewards

Earnings are forecast to grow

NVO Rewards

Trading below its fair value

NVO Rewards

Upgraded on attractively valued

NVO Rewards

Investors confidence is positive

Linked to NVO

Symbol

IQ

Close

Change

LLY

4.21

1032.97

-3.76%

PFE

4.25

25.89

+1.21%

LEXX

1.55

0.73

-6.53%

VKTX

3.90

31.86

-7.21%

SNY

3.94

47.47

-0.88%

NVO Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

74%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

36%

86%

NVO Street Sentiment

NVO Street Sentiment is bullish and have positive views on the near-term outlook

NVO Risk Level

NVO has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.

Click here to check what is your level of risk

Risks Indicators

Investors losing confidence

Hit 52-week low

Low

LOW

HIGH

NVO Performance Sentiment

Sentiments overview associated with NVO events and the stock performance.

74%

16%

Positive

Negative

32 out of 43
events present

7 out of 43
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Support
Price

$58.91

Resistance
Price

$45.68

Current Price Range

$60.00

Show methods +

NVO Latest Analysis

Novo Nordisk Stock Dips As Company Faces GLP-1 Antitrust Lawsuit. ) .Novo Nordisk stock is feeling bearish pressure. Strive Specialties filed a lawsuit on Wednesday in a federal district court in San Antonio Texas alleging that Novo Nordisk and

Today

$57.12 | -3.05%

Momentum

Novo Nordisk stock target raised at UBS ahead of Wegovy Pill launch.

Today

$57.12 | -3.05%

Activity

Potential

Novo Nordisk Foundation grants DKK 5.5 billion to elevate innovation in Denmark and Europe. COPENHAGEN Denmark Jan. 15 2026 /PRNewswire/ -- The Novo Nordisk Foundation has allocated up to DKK 5.5 billion (EUR 736 million) to BioInnovation Institute (BII) a leading institute for life science and deep tech innovation in Copenhagen. The funding will enable BII to expand its...

Today

$57.12 | -3.05%

Activity

Novo Nordisk A/S (NOVO:CA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript.

Tue Jan 13, 2026

$59.61 | -0.34%

Activity

Novo Nordisk Soars 19% in a Month: How Should You Play the Stock?. NVO jumps nearly 19% in a month primarily on the FDA approval and launch of oral Wegovy the first GLP-1 pill for obesity and cardiovascular risk reduction.

Tue Jan 13, 2026

$59.61 | -0.34%

Activity

Momentum

Novo Nordisk flags near-term headwinds in international markets.

Tue Jan 13, 2026

$59.61 | -0.34%

Potential

Can Novo Nordisk Unseat Eli Lilly as the Weight Loss Drug Leader in 2026?. Key PointsNovo Nordisk launched an oral version of its best-selling weight management medicine.

Tue Jan 13, 2026

$59.61 | -0.34%

Activity

Looking At Novo Nordisks Recent Unusual Options Activity. Deep-pocketed investors have adopted a bearish approach towards Novo Nordisk (NYSE:) and it'.s something market players shouldn'.t ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown but such a substantial move in NVO usually suggests something big is about to happen.We gleaned this information from our observations today when Benzinga

Mon Jan 12, 2026

$59.86 | +1.79%

Momentum

Novo Nordisk (NVO) Surpasses Market Returns: Some Facts Worth Knowing. Novo Nordisk (NVO) concluded the recent trading session at $57.34 signifying a 1.36% move from its prior days close.

Thu Jan 8, 2026

$57.34 | +1.37%

Momentum

Novo Nordisk: My Top Pick For 2026.

Thu Jan 8, 2026

$57.34 | +1.37%

Potential

Discover NVO Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of NVO. We're here to help you make informed investment decisions today.

FIND US ON

Receive our NVO Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

NVO Stock trends

NVO Stock performance

NVO Stock analysis

NVO investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing NVO

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing NVO

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

NVO Stock Analysis & IQ Rating | Novo Nordisk A/S

NVO Stock IQ

NVO Target Price

NVO Risk Level

NVO Analysts Opinion

NVO Street Sentiment

NVO Performance Sentiment

Technical Price Levels

Explore our NVO Stock insights

Receive our NVO Daily Alerts

NVO Street Sentiment

NVO Risk Level

Technical Price Levels

Discover NVO Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of NVO. We're here to help you make informed investment decisions today.

Receive our NVO Daily Alerts

NVO Alerts